Patti Bank joined Westwicke in 2015 as a Managing Director, leading our San Francisco effort in Life Sciences. Patti’s focus is working with both public and private companies in the specialty pharma/pharma and biotechnology areas. Her analytical expertise and strong healthcare industry relationships stem from more than 25 years working in the life sciences field, including 20 years as a sell-side analyst and more than five years of industry experience as a senior pharmaceutical medical representative.
Patti worked on Wall Street for over 20 years as a sell-side equity analyst primarily responsible for covering the pharmaceutical and specialty pharmaceutical sectors. During that time, she developed a thorough knowledge of financial analysis, business development, strategic planning and capital markets. Patti has an extensive industry network at the senior management level.
Most recently, Patti was a Managing Director at Discern Analytics. There, she was a founding member of the healthcare team. Her responsibilities included developing a big data analytics platform by monitoring unique data sources uncovering information that could be mapped to spot early investment trends impacting specialty pharmaceutical stocks. Prior to Discern, Patti was a Senior Vice President at Pacific Growth Equities (acquired by Wedbush) and Vector Securities (acquired by Prudential), both research and strategic advisory firms focusing on small-to-mid capitalization healthcare companies. Over the years, she has participated in numerous initial public offerings, capital raises and M&A transactions. Patti has covered companies in multiple therapeutic fields including GI, pain management, diabetes, respiratory, dermatology and CNS.
Patti earned an MBA from Drexel University and a BA in Neurobiology and Economics from Rutgers University. She lives in Virginia with her husband and four children.